+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Iodixanol Injection Market - Global Forecast 2026-2032- Product Image
Iodixanol Injection Market - Global Forecast 2026-2032- Product Image
Sale

Iodixanol Injection Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129149
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Iodixanol Injection Market is projected to reach USD 1.41 Billion in 2026. It is expected to continue growing at a CAGR of 8.02%, reaching USD 2.25 Billion by 2032.

Iodixanol Injection: Executive Summary and Market Context

Iodixanol injection is an iso-osmolar, nonionic iodinated contrast medium used to enhance visualization during diagnostic imaging procedures, including computed tomography, angiography, and urography. Its clinical relevance is linked to the need for reliable image quality while managing contrast-related tolerability considerations. Demand conditions are shaped by imaging volumes, hospital and outpatient diagnostic capacity, regulatory requirements, procurement practices, and clinician preferences.

Imaging Practice and Care-Delivery Changes Reshaping Iodixanol Use

The landscape is being shaped by the expansion of minimally invasive diagnosis, wider access to advanced imaging, and greater attention to patient safety and workflow efficiency. Hospitals and imaging providers are increasingly evaluating contrast agents through a combination of diagnostic performance, renal-risk protocols, adverse-reaction preparedness, supply continuity, packaging, and total treatment cost. Standardized imaging pathways and stronger coordination between radiology, pharmacy, and procurement teams are also influencing product selection.

Artificial Intelligence Is Improving Contrast-Enabled Imaging Workflows

Artificial intelligence is contributing to iodixanol-related workflows primarily through image reconstruction, automated protocol selection, quality assurance, and clinical decision support. AI tools can help technologists tailor scan parameters, identify inadequate enhancement, prioritize urgent findings, and reduce repeat examinations. These applications may improve operational efficiency and support more consistent use of contrast media, although clinical validation, interoperability, cybersecurity, human oversight, and regulatory compliance remain essential.

Regional Insights: Different Imaging Systems Create Distinct Priorities

North America emphasizes advanced imaging utilization, institutional safety protocols, and supply resilience, while Latin America is influenced by uneven access to imaging infrastructure, import requirements, and public-private differences. Europe places strong emphasis on clinical governance, environmental considerations, procurement coordination, and harmonized regulatory expectations. The Middle East is investing in specialized healthcare capacity and advanced diagnostics, whereas Africa continues to face infrastructure, workforce, affordability, and distribution challenges. Asia-Pacific combines rapidly expanding diagnostic capacity with substantial variation across mature and emerging healthcare systems, creating diverse requirements for training, quality assurance, and dependable supply.

Group Insights: Economic and Security Blocs Shape Procurement Conditions

ASEAN markets reflect varied regulatory systems, healthcare funding models, and levels of imaging access, making local registration and distribution capability important. BRICS members span large and diverse healthcare environments in which domestic manufacturing policy, public procurement, and infrastructure development can influence access. The European Union benefits from coordinated regulatory and quality frameworks, although national reimbursement and purchasing practices still differ. G7 systems generally prioritize evidence, safety monitoring, operational efficiency, and resilient supply chains. GCC countries are strengthening tertiary and diagnostic services, while NATO members show varied healthcare structures but share interest in continuity of critical medical supplies and emergency preparedness.

Country Insights: Regulatory, Clinical, and Infrastructure Differences Matter

Australia and Canada combine established healthcare systems with geographically dispersed service delivery. Brazil, Mexico, India, China, and Russia present broad and diverse imaging needs alongside regional differences in infrastructure, procurement, and local production. France, Germany, Italy, Spain, and the United Kingdom emphasize regulated clinical practice, hospital procurement, and safety monitoring, with differences in reimbursement and purchasing organization. Japan and South Korea maintain technologically advanced imaging environments with strong quality expectations. The United States has extensive imaging capacity and sophisticated institutional protocols, with purchasing, reimbursement, and compliance requirements varying across care settings.

Actions for Leaders: Strengthen Safety, Supply, and Workflow Integration

Industry leaders should align product strategy with documented clinical protocols, renal-risk assessment, adverse-reaction management, and evidence-based imaging pathways. They should build resilient, multi-layered supply networks; maintain robust quality and pharmacovigilance systems; and provide practical education for radiologists, technologists, pharmacists, and procurement teams. Integration with dose-management, electronic ordering, and AI-supported workflow tools can improve consistency, provided validation and human oversight are maintained. Regional strategies should account for registration pathways, public procurement rules, cold-chain or storage requirements, sustainability expectations, and differences in healthcare access.

Research Methodology: Structured Review of Clinical and Healthcare-System Evidence

This executive summary is based on a structured interpretation of iodixanol injection’s clinical role and the healthcare conditions that influence its use. The approach considers peer-reviewed medical literature, regulatory and safety documentation, imaging-practice guidance, public healthcare information, procurement considerations, and regional healthcare-system characteristics. Findings are synthesized qualitatively across the specified regions, groups, and countries. No market estimates, market sizing, market shares, or forecasts are presented, and conclusions should be validated against current local regulations and institutional policies.

Conclusion: Reliable Contrast Use Depends on Clinical Value and System Readiness

Iodixanol injection remains relevant where imaging providers seek dependable contrast enhancement alongside careful management of patient safety and operational requirements. The strongest opportunities for responsible adoption are connected to expanding diagnostic access, standardized protocols, digital workflow improvement, and resilient medical-supply planning. Leaders that combine clinical evidence, regulatory discipline, staff training, technology governance, and region-specific execution will be better positioned to support consistent patient care across diverse imaging environments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Iodixanol Injection Market, by Concentration
7.1. Introduction
7.2. 270 Mg Per Milliliter
7.3. 320 Mg Per Milliliter
7.4. 370 Mg Per Milliliter
8. Iodixanol Injection Market, by Delivery Mode
8.1. Introduction
8.2. Prefilled Syringe
8.3. Vial
9. Iodixanol Injection Market, by Packaging
9.1. Introduction
9.2. 100 Milliliter
9.3. 150 Milliliter
9.4. 50 Milliliter
10. Iodixanol Injection Market, by Application
10.1. Introduction
10.2. Cardiovascular Imaging
10.2.1. Coronary Angiography
10.2.2. Peripheral Angiography
10.3. Computed Tomography Imaging
10.3.1. Body Computed Tomography
10.3.2. Head Computed Tomography
10.4. Gastrointestinal Imaging
11. Iodixanol Injection Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Center
11.3. Diagnostic Center
11.4. Hospital
12. Iodixanol Injection Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Iodixanol Injection Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Iodixanol Injection Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Bayer AG
16.2. Beijing Beilu Pharmaceutical Co., Ltd.
16.3. Bracco Imaging S.p.A.
16.4. Chengdu Gaoxiong Pharmaceutical Co., Ltd.
16.5. Cipla Limited
16.6. Daiichi Sankyo Company, Limited
16.7. Dr. Reddy’s Laboratories Ltd.
16.8. Fresenius Kabi AG
16.9. General Electric Company
16.10. Guerbet Group
16.11. Hengrui Medicine
16.12. Hikma Pharmaceuticals PLC
16.13. Intas Pharmaceuticals Ltd.
16.14. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
16.15. Jubilant Pharmova Ltd.
16.16. Lantheus Medical Imaging, Inc.
16.17. Mallinckrodt plc
16.18. Otsuka Pharmaceutical Co., Ltd.
16.19. Pfizer Inc.
16.20. Sagent Pharmaceuticals, Inc.
16.21. Sanochemia Pharmazeutika AG
16.22. Shandong Xinhua Pharmaceutical Co., Ltd.
16.23. Shanghai Nopa Pharmaceutical Co., Ltd.
16.24. Sun Pharmaceutical Industries Ltd.
16.25. Taejoon Pharm Co., Ltd.
16.26. Teva Pharmaceutical Industries Ltd.
16.27. Unijules Life Sciences Ltd.
16.28. Yangtze River Pharmaceutical Group
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Iodixanol Injection Market, Years Considered for the Study
FIGURE 2. Global Iodixanol Injection Market, Research Design
FIGURE 3. Global Iodixanol Injection Market, Research Framework
FIGURE 4. Global Iodixanol Injection Market, Data Triangulation
FIGURE 5. Global Iodixanol Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Iodixanol Injection Market Size, by Concentration, 2025 vs 2032 (%)
FIGURE 7. Global Iodixanol Injection Market Size, by Concentration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Iodixanol Injection Market Size, by Delivery Mode, 2025 vs 2032 (%)
FIGURE 9. Global Iodixanol Injection Market Size, by Delivery Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Iodixanol Injection Market Size, by Packaging, 2025 vs 2032 (%)
FIGURE 11. Global Iodixanol Injection Market Size, by Packaging, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Iodixanol Injection Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Iodixanol Injection Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Iodixanol Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Iodixanol Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Iodixanol Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Iodixanol Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Iodixanol Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Iodixanol Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Iodixanol Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Iodixanol Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Iodixanol Injection Market Segmentation & Coverage
TABLE 2. Global Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 4. Global 270 Mg Per Milliliter Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global 270 Mg Per Milliliter Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global 270 Mg Per Milliliter Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global 320 Mg Per Milliliter Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global 320 Mg Per Milliliter Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global 320 Mg Per Milliliter Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 370 Mg Per Milliliter Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 370 Mg Per Milliliter Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 370 Mg Per Milliliter Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 14. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 21. Global 100 Milliliter Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global 100 Milliliter Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global 100 Milliliter Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global 150 Milliliter Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global 150 Milliliter Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global 150 Milliliter Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global 50 Milliliter Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global 50 Milliliter Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global 50 Milliliter Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 31. Global Cardiovascular Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Cardiovascular Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Cardiovascular Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Coronary Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Coronary Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Coronary Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Peripheral Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Peripheral Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Peripheral Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Computed Tomography Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Computed Tomography Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Computed Tomography Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Body Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Body Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Body Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Head Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Head Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Head Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Gastrointestinal Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Gastrointestinal Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Gastrointestinal Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Global Ambulatory Surgical Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Ambulatory Surgical Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Ambulatory Surgical Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Diagnostic Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Diagnostic Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Diagnostic Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Iodixanol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Iodixanol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. North America Iodixanol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. North America Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 73. North America Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 74. North America Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 75. North America Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. North America Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 77. North America Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 78. North America Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Latin America Iodixanol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Latin America Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 81. Latin America Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 82. Latin America Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 83. Latin America Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Latin America Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 85. Latin America Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 86. Latin America Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Europe Iodixanol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Europe Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 89. Europe Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 90. Europe Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 91. Europe Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Europe Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 93. Europe Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 94. Europe Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Middle East Iodixanol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Middle East Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 97. Middle East Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 98. Middle East Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 99. Middle East Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Middle East Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 101. Middle East Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 102. Middle East Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Africa Iodixanol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Africa Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 105. Africa Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 106. Africa Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 107. Africa Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Africa Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 109. Africa Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 110. Africa Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Global Iodixanol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. ASEAN Iodixanol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. ASEAN Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 114. ASEAN Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 115. ASEAN Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 116. ASEAN Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. ASEAN Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 118. ASEAN Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 119. ASEAN Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. GCC Iodixanol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. GCC Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 122. GCC Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 123. GCC Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 124. GCC Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. GCC Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 126. GCC Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 127. GCC Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. European Union Iodixanol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. European Union Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 130. European Union Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 131. European Union Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 132. European Union Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. European Union Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 134. European Union Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 135. European Union Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. BRICS Iodixanol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. BRICS Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 138. BRICS Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 139. BRICS Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 140. BRICS Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. BRICS Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 142. BRICS Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 143. BRICS Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. G7 Iodixanol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. G7 Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 146. G7 Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 147. G7 Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 148. G7 Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. G7 Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 150. G7 Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 151. G7 Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. NATO Iodixanol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. NATO Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 154. NATO Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 155. NATO Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 156. NATO Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. NATO Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 158. NATO Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 159. NATO Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Global Iodixanol Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. United States Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 162. United States Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 163. United States Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 164. United States Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 165. United States Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. United States Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 167. United States Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 168. United States Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Canada Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 170. Canada Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 171. Canada Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 172. Canada Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 173. Canada Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Canada Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 175. Canada Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 176. Canada Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Mexico Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 178. Mexico Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 179. Mexico Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 180. Mexico Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 181. Mexico Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. Mexico Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 183. Mexico Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 184. Mexico Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Brazil Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 186. Brazil Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 187. Brazil Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 188. Brazil Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 189. Brazil Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Brazil Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 191. Brazil Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 192. Brazil Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. United Kingdom Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 194. United Kingdom Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 195. United Kingdom Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 196. United Kingdom Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 197. United Kingdom Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. United Kingdom Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 199. United Kingdom Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 200. United Kingdom Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. Germany Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 202. Germany Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 203. Germany Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 204. Germany Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 205. Germany Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Germany Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 207. Germany Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 208. Germany Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. France Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 210. France Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 211. France Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 212. France Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 213. France Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. France Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 215. France Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 216. France Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Russia Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 218. Russia Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 219. Russia Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 220. Russia Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 221. Russia Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Russia Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 223. Russia Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 224. Russia Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Italy Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 226. Italy Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 227. Italy Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 228. Italy Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 229. Italy Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Italy Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 231. Italy Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 232. Italy Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Spain Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 234. Spain Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 235. Spain Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 236. Spain Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 237. Spain Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. Spain Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 239. Spain Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 240. Spain Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. China Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 242. China Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 243. China Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 244. China Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 245. China Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. China Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 247. China Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 248. China Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. India Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 250. India Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 251. India Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 252. India Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 253. India Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. India Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 255. India Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 256. India Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. Japan Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 258. Japan Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 259. Japan Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 260. Japan Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 261. Japan Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Japan Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 263. Japan Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 264. Japan Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Australia Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 266. Australia Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 267. Australia Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 268. Australia Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 269. Australia Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. Australia Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 271. Australia Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 272. Australia Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. South Korea Iodixanol Injection Market Size, 2017-2032 (USD Million)
TABLE 274. South Korea Iodixanol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 275. South Korea Iodixanol Injection Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 276. South Korea Iodixanol Injection Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 277. South Korea Iodixanol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. South Korea Iodixanol Injection Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 279. South Korea Iodixanol Injection Market Size, by Computed Tomography Imaging, 2017-2032 (USD Million)
TABLE 280. South Korea Iodixanol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. Global Iodixanol Injection Market Share, by Key Player, 2025
TABLE 282. Global Iodixanol Injection Market, Key Experts

Companies Mentioned

  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Imaging S.p.A.
  • Chengdu Gaoxiong Pharmaceutical Co., Ltd.
  • Cipla Limited
  • Daiichi Sankyo Company, Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Fresenius Kabi AG
  • General Electric Company
  • Guerbet Group
  • Hengrui Medicine
  • Hikma Pharmaceuticals PLC
  • Intas Pharmaceuticals Ltd.
  • Jiangsu Chia Tai‑Tianqing Pharmaceutical Co., Ltd.
  • Jubilant Pharmova Ltd.
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt plc
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Sagent Pharmaceuticals, Inc.
  • Sanochemia Pharmazeutika AG
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Shanghai Nopa Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Taejoon Pharm Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Unijules Life Sciences Ltd.
  • Yangtze River Pharmaceutical Group

Related Topics

Related Reports

Iodixanol (CAS 92339-11-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Iodixanol (CAS 92339-11-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Contrast Injection Lines Market Report 2026 - Product Image

Contrast Injection Lines Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Shen Mai Injection Market - Global Forecast 2026-2032 - Product Image

Shen Mai Injection Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Bacteriostatic Water for Injection Market - Global Forecast 2026-2032 - Product Image

Bacteriostatic Water for Injection Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Self-Injections Market Report 2026 - Product Image

Self-Injections Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.